- Home
- SHLT vs CALC Comparison
SHLT vs CALC Comparison
Compare SHLT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- CALC
- Stock Information
- Founded
- SHLT 1987
- CALC 2011
- Country
- SHLT Israel
- CALC United States
- Employees
- SHLT N/A
- CALC N/A
- Industry
- SHLT Business Services
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- SHLT Consumer Discretionary
- CALC Health Care
- Exchange
- SHLT Nasdaq
- CALC Nasdaq
- Market Cap
- SHLT 46.9M
- CALC 40.3M
- IPO Year
- SHLT N/A
- CALC N/A
- Fundamental
- Price
- SHLT $2.88
- CALC $3.09
- Analyst Decision
- SHLT Strong Buy
- CALC Strong Buy
- Analyst Count
- SHLT 1
- CALC 5
- Target Price
- SHLT $11.00
- CALC $18.20
- AVG Volume (30 Days)
- SHLT 6.3K
- CALC 26.8K
- Earning Date
- SHLT 09-26-2024
- CALC 11-13-2024
- Dividend Yield
- SHLT N/A
- CALC N/A
- EPS Growth
- SHLT N/A
- CALC N/A
- EPS
- SHLT N/A
- CALC N/A
- Revenue
- SHLT $55,939,000.00
- CALC N/A
- Revenue This Year
- SHLT N/A
- CALC N/A
- Revenue Next Year
- SHLT N/A
- CALC N/A
- P/E Ratio
- SHLT N/A
- CALC N/A
- Revenue Growth
- SHLT N/A
- CALC N/A
- 52 Week Low
- SHLT $2.54
- CALC $2.05
- 52 Week High
- SHLT $8.14
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- SHLT 49.41
- CALC 50.07
- Support Level
- SHLT $2.69
- CALC $2.73
- Resistance Level
- SHLT $3.21
- CALC $3.28
- Average True Range (ATR)
- SHLT 0.21
- CALC 0.29
- MACD
- SHLT -0.01
- CALC 0.02
- Stochastic Oscillator
- SHLT 41.07
- CALC 42.00
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.